“Speculative But Promising”: A Newly IPO-ed Biotech With A Very Different Approach To Psychedelics
“New therapies derived from psychedelic compounds…are offering hope, not to mention a slew of opportunities for forward-thinking investors.”
IPO-ed Biotechs